Arena Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Arena Pharmaceuticals Inc

Arena Pharmaceuticals is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has one product on the market and several others in development. Lorcaserin is used long term for weight loss in those who are obese. It works by increasing feelings of fullness so that less food is eaten. The U.S. Food and Drug Administration (FDA) approved Lorcaserin on June 27, 2012. Arena Pharmaceuticals is headquartered in Zofingen, Switzerland.

REFINE BY

KEYWORD

Inflammatory bowel disease (IBD) - Market Insights, Epidemiology, and Market Forecast - 2030

 Report
January 2022
130 Pages
Global

From

€6612EUR$6,950USD£5,628GBP

Eosinophilic Esophagitis - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€7135EUR$7,500USD£6,073GBP

Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Regional Outlook and Forecast, 2022 - 2028

 Report
August 2022
170 Pages
Global

From

€3425EUR$3,600USD£2,915GBP

5-HT2C Agonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1189EUR$1,250USD£1,012GBP

Cannabinoid Agonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1189EUR$1,250USD£1,012GBP

NEED HELP FINDING THE RIGHT PRODUCT? Dale will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1189EUR$1,250USD£1,012GBP

Global Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Cancer Type, Route of Administration, Drug Class, Product, and End User

 Report
April 2022
233 Pages
Global

From

€3030EUR$3,185USD£2,579GBP

€4329EUR$4,550USD£3,685GBP

Circadian Rhythm Sleep Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
83 Pages
Global

From

€3500EUR$3,941USD£3,084GBP

Narcolepsy Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
110 Pages
Global

From

€3500EUR$3,941USD£3,084GBP

Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1189EUR$1,250USD£1,012GBP

Sleep Wake Disorder Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
84 Pages
Global

From

€3500EUR$3,941USD£3,084GBP

Narcolepsy Drugs Market by Disease and Therapeutic Type: Global Opportunity Analysis and Industry Forecast, 2021-2030

 Report
September 2021
198 Pages
Global

From

€3531EUR$3,712USD£3,006GBP

Europe Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
70 Pages
Europe

From

€1427EUR$1,500USD£1,215GBP

LAMEA Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
70 Pages
Middle East, Africa

From

€1427EUR$1,500USD£1,215GBP

Asia Pacific Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
70 Pages
Asia Pacific

From

€1427EUR$1,500USD£1,215GBP

North America Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
61 Pages
North America

From

€1427EUR$1,500USD£1,215GBP

Narcolepsy Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2022
99 Pages
Global

From

€3500EUR$3,941USD£3,084GBP

Sphingosine 1-Phosphate Receptor 1 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
101 Pages
Global

From

€3500EUR$3,941USD£3,084GBP

North America Narcolepsy Market to 2027 - Regional Analysis and Forecasts By Type; Distribution Channel and Country

 Report
January 2020
118 Pages
North America

From

€1998EUR$2,100USD£1,701GBP

€2854EUR$3,000USD£2,429GBP

Europe Narcolepsy Market to 2027 - Regional Analysis and Forecasts By Type; Distribution Channel and Country

 Report
January 2020
123 Pages
Europe

From

€1998EUR$2,100USD£1,701GBP

€2854EUR$3,000USD£2,429GBP

134 Results (Page 6 of 7)
- 1
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.